AyoHealth distributes NAFDAC-cleared rapid test kits, assembles bundled diagnostic kits for fever, maternal health, neonatal risk, and diabetes — and powers every pharmacist, clinic, and patient with a WhatsApp AI intelligence layer. No competitor does all three.
Nigeria is simultaneously the world's biggest malaria burden country, the largest contributor to global maternal mortality, and home to 11.4 million diabetics — yet its private diagnostic infrastructure is deeply fragmented and underserved.
| Level | Scope | Value |
|---|---|---|
| TAM | Africa POC Diagnostics Market | $691M (2025) |
| SAM | Nigeria IVD Market | $41.3M (2025) |
| SOM | Lagos + Abuja private sector | ~$2.5–3.5M Y1 |
Key tailwind: Nigeria's 2024 Executive Order suspended all import duties and VAT on rapid diagnostic kits — dramatically reducing cost of goods and boosting distributor margins. A 2-year window of zero tariffs is active now.
Nigeria's diagnostic sector is served by physical-only distributors and drug-focused tech platforms — none of which combines diagnostic bundling with pharmacist AI intelligence.
The only player combining physical distribution, bundled clinical kits, and a WhatsApp pharmacist + patient intelligence platform in a single integrated business.
AyoHealth operates at the intersection of physical supply chain, clinical bundling, and data intelligence — creating defensibility that no single-layer competitor can replicate.
"AyoHealth is Nigeria's diagnostic backbone — delivering the right test to the right outlet at the right time, while giving every pharmacist, clinic, and patient the intelligence to act on the result."
NAFDAC-cleared RDTs delivered to pharmacies, PPMVs, clinics, and labs across Lagos and Abuja. Zero-tariff import window reduces COGS by 15–25%.
Four proprietary kit SKUs — Fever Diagnostic, Maternal Health, Neonatal Risk, and NCD Monitoring — assembled to clinical use-case specifications.
WhatsApp AI assistants for pharmacists (AyoPharm), clinics (AyoClinic), and patients (AyoCheck). Disease surveillance. Real-time inventory tracking.
| Kit | Contents | Target Channel | Wholesale Price | Gross Margin |
|---|---|---|---|---|
| Fever Diagnostic Kit | Malaria RDT + Typhoid RDT + Thermometer | PPMVs, Pharmacies | ₦3,500 | ~57% |
| Maternal Health Kit | Pregnancy + Malaria + Hemoglobin + UTI strip | Clinics, ANC centres | ₦7,000 | ~57% |
| Neonatal Risk Kit | CRP + Infection marker + Malaria RDT | Hospitals, MCH clinics | ₦11,000 | ~55% |
| NCD Monitoring Kit | Glucometer + 50 strips + 25 lancets | Pharmacies, corporate | ₦18,000 | ~55% |
Three structural tailwinds create urgency. Six key risks have clear mitigation strategies.
Codix Bio urgently needs commercial distributors after US funding cuts. First-movers get preferred pricing and supply agreements.
2024 Executive Order: zero tariffs and VAT on RDT imports for 2 years. AyoHealth must move now to lock in supply contracts under this regime.
Nigeria's new digital pharmacy regulation creates a legitimised channel. AyoHealth can be the first registered diagnostic-focused distributor.
120 working day process can stall launch.
Nigeria's market has significant counterfeit medical product infiltration.
Import costs in USD while revenue is in naira creates margin risk.
Cultural habit of presumptive diagnosis suppresses test uptake.
Nigeria Data Protection Regulation requires explicit consent and data governance.
Inventory cycle vs. net-30 client payment terms creates cash gap.
Three phases with hard milestones, specific action steps, and measurable KPIs at every gate.
Minimum viable launch at ₦10–12M; comfortable build-out at ₦20–25M. Blended gross margin of 52–58% on all kit SKUs.
| Category | Min (₦) | Realistic (₦) |
|---|---|---|
| Initial Inventory (6–8 SKUs) | 5,000,000 | 8,000,000 |
| NAFDAC Registration (4–6 SKUs) | 600,000 | 1,500,000 |
| CAC + PCN + State MoH | 300,000 | 600,000 |
| Lagos Warehouse (6 months) | 750,000 | 1,500,000 |
| Abuja Depot | 400,000 | 700,000 |
| WhatsApp AI Platform | 500,000 | 2,000,000 |
| Branding + Marketing | 500,000 | 1,200,000 |
| Working Capital Buffer | 2,000,000 | 4,000,000 |
| Total | ₦10.85M | ₦21.8M |
B2B acquisition through pharmacist field sales and community WhatsApp groups. B2C growth through the AyoCheck symptom chatbot and short-form health education content.
4 reps × 10–15 outlet visits/day in Ikeja, Surulere, Lekki, Maitama, Wuse corridors. Starter pack: ₦50K order → 10% free stock + free WhatsApp onboarding.
Partner with 20–30 key WhatsApp group admins per LGA. Distribute sample kits + AyoPharm onboarding. Zero cost; enormous reach in Nigeria's pharmacist networks.
Register with PSN and ACPN; sponsor quarterly conferences. Direct access to 6,500+ registered Lagos + Abuja pharmacists.
Symptom checker → recommended test → nearest outlet. Natural virality in patient communities. Zero incremental cost per user after build.
"Malaria vs. Typhoid symptoms", "When to test your glucose", "Signs of pregnancy complications." 4× Instagram + 3× TikTok per week. CTA to WhatsApp chatbot.
Low-competition, high-intent keywords: "pregnancy test kit Lagos", "glucometer strips Abuja", "malaria test near me." Expected CPC: ₦80–200.
Expected B2B CAC: ₦3,000–6,000 per pharmacy account. Expected 24-month LTV: ₦360,000–720,000. LTV:CAC ratio: 60–120×.
800+ active B2B clients. Convert 30% to paid AyoIntel SaaS (₦720K–1.9M MRR from subscriptions alone). Win 2–3 state/NGO procurement contracts. Publish first AyoData intelligence report.
Nigeria's 3rd and 4th largest cities. Oil-sector middle class in PH drives strong NCD kit demand. Ibadan's large PPMV network ideal for fever kit distribution. Jumia Health + Konga e-commerce integration.
Target ₦150–300M seed from Ventures Platform, Novastar, Partech Africa. AyoIntel v3 with Hausa/Yoruba NLP and voice input. Pitch Lagos State MoH on disease surveillance data partnership.
Priority: domestic suppliers first, then African regional, then direct international. All must be WHO-prequalified or NAFDAC-cleared.
| Supplier | Location | Products | Priority | Notes |
|---|---|---|---|---|
| Codix Bio | Ogun State, Nigeria | Malaria, HIV, Hep B RDTs; 147M kits/yr capacity | Domestic #1 | WHO-licensed; SD Biosensor partner; domestic pricing advantage |
| Revital Healthcare | Kilifi, Kenya | HIV, Malaria, HCG, Hep B/C, Dengue, Syphilis | Africa Regional | First end-to-end African RDT manufacturer; expanding to Nigeria |
| SD Biosensor | Suwon, South Korea | Full RDT range: malaria, pregnancy, glucose (WHO-PQ) | International A | Via Africa Medical Supplies Platform; Codix Bio partnership |
| Evancare Medical | Nantong, China | Pregnancy, UTI, CRP, ovulation strips; CE/ISO certified | International B | Direct export; low MOQ; sample availability for trial orders |
| Wigmore Wholesale | Pan-Africa | Contour Next glucometer strips; diabetes consumables | Diabetes Specialist | Authentic brands; competitive wholesale pricing |
| Scantrik Medical | Lagos, Nigeria | Malaria, HIV, Dengue RDTs (wholesale) | Interim Backup | Use before NAFDAC own-clearance is received |
Regulatory requirement: Submit every imported lot for testing at the ANDI Centre of Excellence for Malaria Diagnosis, University of Lagos (andimalariacentre@unilag.edu.ng) per WHO guidelines. This is free and mandatory for all malaria RDT lots.